Stock info DSM-Firmenich | Filter Basic-Info
Stock: DSM-Firmenich (NL Amsterdam 25), ISIN: NL0000009827
| Last Price | 94.38 | Max Price | 94.38 |
| Min Price | 81.84 | 1 Year return | -0.51 |
| Avg. Target | 87.57 | Expected Return | -7.21 % |
| Sector | Basic Materials | Subsector | Chemicals |
| Sell | 0 | Rating |
|
| Hold | 2 | Concensus |
 
|
| Buy | 5 | ||
| Annual report 2018 |
DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. DSM’s products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM has annual sales of over € 8 billion and employs some 22,000 people worldwide. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas.
Loading...
DSM activities
DSM is a popularly known multinational Dutch company that mostly focuses on nutrition and health materials. The company has a well spread branches while it’s headquarter is located in Heerlen, a city in the South East of Netherlands. Towards the end of 2017, the DSM had hired over 21,000 people in its branches all over the 50 countries. In the same year, the company, registered sales totaling to €8,631 million.
DSM is organized into business groups or clusters which are further categorized according to the products and market formation. Each business group has its own director who must report to managing Board. In 2015 the DSM groups were placed in three categories:
Materials
This consists of Functional Materials, DSM Resins, DSM Dyneema and DSM engineering plastics. These materials serves various purposes for example; DSM Resins are used to make resins for making inks and paints and engineering plastics for electrical components.
Nutrition
This cluster mainly deals with DSM food supplies and Nutritional products. DSM nutrition provides nutrients such as lipid, vitamins and carotenoids all of which are synthetic. Some of DSM’s food specialties includes; yeast extracts, hydrocolloids and enzymes.
Innovation center
This cluster is purposed for managing company’s business ideas alongside strengthening innovation.
Contact info:Street: 6401 JH HeerlenPostbox: P.O. Box 6500City: HeerlenCountry: NetherlandsPhone: 31 (0)45 578 28Website: www.dsm.com
Sector Review DSM-Firmenich
Loading...
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 0 | 647,530 | 0.00 % |
| 2020 | 0 | 586,506 | 0.00 % |
| 2021 | 11,444 | 764,397 | 1.50 % |
| 2022 | 8,390 | 900,685 | 0.93 % |
| 2023 | 10,627 | 783,698 | 1.36 % |
Advice DSM-Firmenich
News DSM-Firmenich
Analysts foresee more revenue DSM
Over the current book year the total revenue from the company in Heerlen will be 9.92 billion euros (consensus estimates). This is quite more than 2022's revenue of 8.39 billion euros. Historical revenues and results DSM plus estimates 2023 The analysts...
Analysts expect over 2020 decreasing revenue DSM
Tomorrow the Dutch company DSM will publish its past quarters results. Over the current book year the total revenue from the company in Heerlen will be 8.44 billion euros (consensus estimates). This is slightly lower than 2019's revenue of 9.01 billion euros....
Share DSM trading with a premium in chemical sector
The Dutch stock DSM is traded with one the highest CAPE-ratios of the chemical companies. Currently the share is now traded at 425 times the past 10 year's average EPS (CAPE / Shiller PE). With this the stock trades way higher than the average US stock of the...
2020 best year, 2008 worst year for DSM
DSM-investors have very good for long times. Even without dividend payments the stock is one of the outperformers from as well chemical sector as the Dutch exchange. The received dividends are a cherry on the cake for investors. The matrix above shows DSM's...
Analysts count on sales decrease DSM
Over the current book year the total revenue will be 8,92 billion euros (consensus estimates). This is slightly lower than 2019's revenue of 9,01 billion euros. Historical revenues and results DSM plus estimates 2020 DSM Delft building © DSM The analysts...
Annual reports DSM-Firmenich
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile DSM-Firmenich
No Records Found
Results DSM-Firmenich
| Resultat |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Intäkter |
|
|
|
|
|
| Kostnader |
|
|
|
|
|
| Vinst |
|
|
|
|
|
| Vinstmarginal |
|
|
|
|
|
| Avkastning på investering |
|
|
|
|
|
Balance DSM-Firmenich
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
Details DSM-Firmenich
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
0.0
|
0.0
|
0.0
|
0.0
|
94.38
|
| Eps |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Stocks |
0
|
0
|
0
|
0
|
|
| Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
|
Dividend DSM-Firmenich
Price info DSM-Firmenich
|
Date
|
Price
|
|---|---|
|
11 Aug 2026
|
94.38
|
|
07 Aug 2026
|
93.70
|
|
06 Aug 2026
|
93.20
|
|
28 Jul 2026
|
81.84
|
|
14 Jul 2026
|
83.82
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x |
©2026 ValueSpectrum. All Rights Reserved
Developed and maintained by 